← Eichor
Study identifier: NCT05048251 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Individually Targeted Neuromodulation for Contamination-based OCD

Condition: Obsessive-Compulsive Disorder  ·  Sponsor: Mclean Hospital

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersNo

About this study

Patients with obsessive-compulsive disorder (OCD) experience a wide array of different types of obsessions and compulsions. However, current treatments for OCD employ a "one size fits all" approach and are used for all patients regardless of symptom type. In this project, the investigators propose to investigate whether a novel method of transcranial magnetic stimulation specifically reduces contamination/washing symptoms - one of the most common types of OCD.

This description comes directly from the study's public registry record.

Talk to the study team

Rosalind Sokoll  ·  617-855-2911  ·  rsokoll@mgh.harvard.edu

Always discuss trial participation with your own doctor first.

Locations (1)

McLean HospitalBelmont, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05048251